MOT C peptide (MOTS-c) is a mitochondrial-derived peptide studied for metabolism and insulin sensitivity. Here's what research shows — and what it doesn't.
MOT C peptide — usually written as MOTS-c, short for mitochondrial open reading frame of the 12S rRNA type-c — is a 16-amino-acid peptide made inside mitochondria that researchers study for its role in metabolism, insulin sensitivity, and exercise capacity. It is not an approved drug, it has no established human dose, and nearly all of the published evidence comes from mice and cell cultures rather than people. Anyone seeing it sold as a fat-burning or anti-aging breakthrough should know that the marketing runs well ahead of the science.
Below is a plain-language look at what MOTS-c is, what the research actually shows, how it compares with other research peptides, and what the legal and safety picture looks like in the United States.
What Is MOT C Peptide?
MOTS-c is a mitochondrial-derived peptide, which means it is encoded by DNA inside the mitochondria rather than by the nuclear genome. Its sequence comes from a short open reading frame within the 12S rRNA gene region of mitochondrial DNA — the phrase "mitochondrial open reading frame of the 12S rRNA type c" is simply the long-form name behind the acronym.
- Size: 16 amino acids, making it far smaller than most protein-based drugs.
- Origin: Encoded in mitochondrial DNA within the 12S rRNA region.
- Discovery: Described in 2015 by researchers at the University of Southern California.
- Family: One of several mitochondrial-derived peptides, alongside humanin and the small humanin-like peptides.
- Circulation: Detectable in blood, and observational studies in people suggest levels shift with age and metabolic health.
Some searches use the phrase "RNA type C-peptide" and land on MOTS-c pages by mistake. C-peptide is a completely different molecule — a fragment released when the pancreas converts proinsulin into insulin. The two are unrelated in structure, origin, and function.
How MOTS-c Is Thought to Work
MOTS-c does not behave like a classic hormone. Under metabolic stress, it appears to travel from the mitochondria into the nucleus and influence the expression of nuclear genes, a process researchers call retrograde signaling.
In laboratory models, the peptide has been linked to several effects:
- AMPK activation: AMPK is a cellular energy sensor, and switching it on shifts metabolism toward energy production.
- Folate and methionine cycle effects: MOTS-c can inhibit enzymes in these pathways, which raises a compound called AICAR and influences purine metabolism.
- Glucose handling: Mouse studies report improved insulin sensitivity and better blood sugar control in diet-induced obesity models.
- Exercise capacity: In mice, MOTS-c administration has been described as an "exercise mimetic," improving running performance without training.
These findings are genuinely interesting. They are also, so far, findings about mice and cells.
What Human Research Actually Shows
There is no published randomized controlled trial of MOTS-c in humans. That is the single most important fact to understand about this peptide.
Human data is limited to observational studies, which measure how much MOTS-c circulates in blood and look for correlations. Some of that work links lower circulating MOTS-c with insulin resistance, obesity, and older age. Correlation is not causation, and no observational study can show that raising MOTS-c levels would improve anyone's health.
That gap matters because online discussions of a mot c peptide dosage are built on animal data, extrapolation, and vendor claims rather than human dose-finding research. There is no agreed human dose, no established schedule, and no controlled safety data in people.
MOTS-c Compared With Other Research Peptides
MOTS-c is often discussed alongside other peptides sold for laboratory research. The table below summarizes how they differ.
| Peptide | Primary research focus | Human clinical data | FDA-approved for human use |
|---|---|---|---|
| MOTS-c | Metabolic regulation, insulin sensitivity, exercise capacity | Observational only | No |
| AOD-9604 | Fat metabolism (growth hormone fragment) | Small, limited trials | No |
| BPC-157 | Tissue repair and gut healing in animal models | Very limited | No |
| TB-500 | Cell migration and tissue repair in animals | None for this use | No |
None of these compounds is approved by the FDA for human use, and each one has a research record thinner than its online reputation suggests. MOTS-c stands out mainly because its mechanism is unusual: it is one of the few peptides that talks to the nucleus from the mitochondria.
Delivery Formats and Common Questions
Research peptides are typically sold as lyophilized powder for injection, as capsules, or as nasal sprays. Delivery-format debates are common across the category — people weighing aod 9604 peptide capsules against injectable forms, for example, are asking a question that applies just as well to MOTS-c. Nasal delivery is another option, and searches for aod 9604 peptide nasal spray reflect that interest.
Timing questions come up constantly too. Someone wondering when to take aod 9604 peptide is usually looking for a schedule that does not exist in the peer-reviewed literature, and the same is true for MOTS-c. No human study has established an optimal time of day, dosing frequency, or cycle length for this peptide.
Safety, Sourcing, and Legal Status
MOTS-c is not FDA-approved for human use in the United States. It is not a dietary supplement and cannot legally be sold as one. Products labeled "for research use only" are intended for laboratory work, not human consumption, even when vendors sell them to individuals.
Anyone researching this category should keep a few points in mind:
- Purity and identity: Third-party certificates of analysis are a baseline, and even those can be forged. The same caution applies to where to buy bpc-157 peptide or any other compound sold this way.
- Sterility: Injectable products made without pharmaceutical-grade manufacturing carry infection risk.
- Unknown interactions: Without human trials, interactions with diabetes, blood pressure, or thyroid medications are simply unknown.
- Sport: MOTS-c appears on the World Anti-Doping Agency's Prohibited List, so athletes subject to drug testing should assume it is banned.
MOTS-c is a legitimate and fast-moving area of basic metabolic research. It is not a proven therapy, and it will not become one until controlled human trials are published. Talk with a healthcare professional before using any unapproved peptide, and stay skeptical of vendors promising results the published research does not support.
Frequently Asked Questions
What is MOT C peptide used for?
MOT C peptide has no approved medical use in the United States. Researchers study it for its role in metabolic regulation, insulin sensitivity, and exercise capacity, but that work is almost entirely preclinical. Any "use" described by vendors is not backed by human clinical trials.
Does MOTS-c help with weight loss?
There is no human trial evidence that MOTS-c causes weight loss in people. Mouse studies have reported metabolic and exercise-related effects, and those results are frequently presented as proof of fat loss, which they are not. Weight loss claims for MOTS-c are marketing claims rather than clinical findings.
Is MOT C peptide legal or FDA-approved in the US?
MOTS-c is not FDA-approved for human use and cannot legally be sold as a dietary supplement. It is commonly sold online as a research chemical labeled "for research use only," which means it is not intended for human consumption. Athletes should also note that MOTS-c appears on WADA's Prohibited List.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.